Last reviewed · How we verify
GSK MMR Vaccine (PRIORIX)
GSK MMR Vaccine (PRIORIX) is a Live attenuated vaccine Biologic drug developed by Shanghai Institute Of Biological Products. It is currently in Phase 3 development for Prevention of measles, mumps, and rubella in children and adults.
PRIORIX is a live attenuated vaccine that stimulates the immune system to produce antibodies and cellular immunity against measles, mumps, and rubella viruses.
PRIORIX is a live attenuated vaccine that stimulates the immune system to produce antibodies and cellular immunity against measles, mumps, and rubella viruses. Used for Prevention of measles, mumps, and rubella in children and adults.
At a glance
| Generic name | GSK MMR Vaccine (PRIORIX) |
|---|---|
| Sponsor | Shanghai Institute Of Biological Products |
| Drug class | Live attenuated vaccine |
| Modality | Biologic |
| Therapeutic area | Immunology / Infectious Disease |
| Phase | Phase 3 |
Mechanism of action
The vaccine contains weakened (attenuated) strains of measles, mumps, and rubella viruses that replicate in the body without causing disease, triggering both humoral (antibody) and cell-mediated immune responses. This immunological memory protects against infection with wild-type viruses upon future exposure. The vaccine is administered intramuscularly or subcutaneously and typically provides lifelong immunity.
Approved indications
- Prevention of measles, mumps, and rubella in children and adults
Common side effects
- Injection site reactions (pain, redness, swelling)
- Fever
- Rash
- Parotitis
- Arthralgia/arthritis
Key clinical trials
- Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants (PHASE3)
- Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months (PHASE3)
- Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life (PHASE3)
- Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age (PHASE3)
- Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine (PHASE4)
- Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan. (PHASE3)
- Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GSK MMR Vaccine (PRIORIX) CI brief — competitive landscape report
- GSK MMR Vaccine (PRIORIX) updates RSS · CI watch RSS
- Shanghai Institute Of Biological Products portfolio CI
Frequently asked questions about GSK MMR Vaccine (PRIORIX)
What is GSK MMR Vaccine (PRIORIX)?
How does GSK MMR Vaccine (PRIORIX) work?
What is GSK MMR Vaccine (PRIORIX) used for?
Who makes GSK MMR Vaccine (PRIORIX)?
What drug class is GSK MMR Vaccine (PRIORIX) in?
What development phase is GSK MMR Vaccine (PRIORIX) in?
What are the side effects of GSK MMR Vaccine (PRIORIX)?
Related
- Drug class: All Live attenuated vaccine drugs
- Manufacturer: Shanghai Institute Of Biological Products — full pipeline
- Therapeutic area: All drugs in Immunology / Infectious Disease
- Indication: Drugs for Prevention of measles, mumps, and rubella in children and adults
- Compare: GSK MMR Vaccine (PRIORIX) vs similar drugs
- Pricing: GSK MMR Vaccine (PRIORIX) cost, discount & access